Skip to main content

Table 1 Characteristics of the controlled versus uncontrolled groups with office blood pressure measurement

From: Comparison between central and ambulatory blood pressure measurements in early detection of end organ damage: a single-center prospective non-randomized controlled trial

Variable Controlled, N = 50 Uncontrolled, N = 50 P All, N = 100
Male 12 (24%) 15 (30%) 0.499 27 (27%)
Female 38 (76%) 35 (70%) 73 (73%)
Age 48.1 ± 7.75 46.94 ± 8.96 0.490 47.52 ± 8.35
BMI 32.7 ± 5.6 31 ± 5.22 0.119 31.85 ± 5.45
Smoking 12 (24%) 13 (26%) 0.817 25 (25%)
Duration of HTN 6.78 ± 4.47 6.1 ± 3.73 0.411 6.44 ± 4.11
F. history 28 (56%) 27 (54%) 0.841 55 (55%)
Office systolic 135.12 ± 19.45 143.56 ± 29.4 0.087 138.58 ± 24.25
Office diastolic 88.53 ± 16.65 85.37 ± 15.04 0.341 87.33 ± 16.05
ABPM systolic 125.15 ± 17.93 128.96 ± 25.9 0.395 126.05 ± 20.42
ABPM diastolic 87.63 ± 18.52 86.04 ± 12.47 0.616 86.84 ± 15.99
Night
 Dipper 36 (72%) 30 (60%) 0.205 66 (66%)
 Not dipper 14 (28%) 20 (40%) 34 (34%)
Central systolic 126.07 ± 19.41 130.63 ± 27.61 0.348 127.44 ± 22.14
Central diastolic 89.49 ± 17.93 88.77 ± 13.89 0.831 89.21 ± 16.40
PWV 7.25 ± 1.09 7.8 ± 1.33 0.024* 7.52 ± 1.24
Augmentation index 24.3 ± 9.71 25.84 ± 11.75 0.477 25.07 ± 10.75
MAP 102.42 ± 16.27 98.88 ± 14.53 0.254 100.65 ± 15.45
Cr 0.8 ± 0.31 1.04 ± 0.34 0.000** 0.92 ± 0.35
GFR 118.04 ± 48.29 94.88 ± 51.17 0.022* 106.46 ± 50.85
LVMI 0.92 ± 0.12 0.95 ± 0.13 0.311 0.93 ± 0.13
EF 59.34% ± 5.69% 59.12% ± 5.83% 0.849 59.23% ± 5.73%
CIMT 0.7 ± 0.12 0.77 ± 0.14 0.008** 0.74 ± 0.13
ABI 0.91 ± 0.2 0.95 ± 0.27 0.322 0.93 ± 0.24
  1. BMI body mass index, HTN hypertension, ABPM ambulatory blood pressure monitoring, PWV pulse wave velocity, MAP mean arterial pressure, Cr creatinine, GFR glomerular filtration ratio, LVMI left ventricular mass index, EF ejection fraction, CIMT carotid intimal thickness, ABI ankle brachial index
  2. * Statistically significant difference (p < 0.05), **highly statistically significant difference (p < 0.01)